The original success of Sildenafil undeniably transformed the pharmaceutical landscape, but betting in companies strongly reliant on generic versions presents a uncertain picture. Despite early earnings were significant, the cessation of patents and the rise of cheaper alternatives have weakened market share. Therefore, a thorough evaluation of cur